Emerging Therapies in Endocrine Oncology: Molecular Targets, Precision Medicine, and Future Directions

Engineering notes

Key topics: autonomous driving. See the paper for implementation details and experimental results.

Chinese explanation / 中文解读

中文解读待补充：本站会优先为端到端自动驾驶、BEV感知、3D目标检测、轨迹预测、路径规划、LiDAR感知等高价值论文补充中文说明。

Original abstract

Endocrine oncology is at a pivotal moment. The traditional pillars of therapy—hormonal manipulation, cytotoxic chemotherapy, and surgical intervention—are being powerfully augmented by a wave of biological insight and technological innovation. As the preceding chapters demonstrate so comprehensively, we are moving from an era defined by histology and clinical syndromes toward one defined by molecular profiles, immune landscapes, and dynamic, theranostic strategies. The complexity of these tumors, from the indolent but heterogeneous neuroendocrine neoplasms to the fiercely aggressive anaplastic thyroid carcinoma, demands a precision that was unimaginable just a decade ago.The challenge for clinicians today is no longer simply recognizing a disease; it is deciphering its unique biological fingerprint. This requires an integration of genomic data, functional imaging, immune microenvironment analysis, and a deep understanding of complex signaling networks. The explosion of targeted agents—from multi-kinase inhibitors to highly selective RET and BRAF blockers—alongside immunotherapy and peptide receptor radionuclide therapy, has dramatically expanded the therapeutic arsenal. Yet, these new powers are not without their complexities. They are accompanied by distinct toxicities, intricate mechanisms of acquired resistance, and the critical need for biomarker-driven patient selection. The journey from a molecular alteration to a rational combination therapy is intricate, requiring both foundational knowledge and a forward-looking perspective.It is precisely to navigate this complex and rapidly evolving landscape that Emerging Therapies in Endocrine Oncology: Molecular Targets, Precision Medicine, and Future Directions, edited by Dr. Farnaz Saberian and Sina Homaee, has been created. This comprehensive volume brings together leading voices to illuminate the full spectrum of contemporary endocrine oncology. Readers will gain a deep understanding of the biologic rationale underpinning new therapies, from the MAPK and PI3K-AKT-mTOR pathways to the intricacies of the tumor microenvironment. The book provides incisive reviews of current clinical practice, critical analyses of resistance mechanisms, and a roadmap for the future, covering the promise of novel cellular therapies, epigenetics, and data-driven decision-making.As a publisher dedicated to advancing open-access medical knowledge, InfoPub Press is proud to present this essential resource to the global oncology community. We believe this book will serve as an invaluable companion for oncologists, endocrinologists, researchers, and all perioperative professionals who are dedicated to translating scientific discovery into meaningful advances for patients with endocrine malignancies. It equips its readers not just to manage change, but to lead it, ensuring that the promise of precision medicine is fulfilled for every patient.

Links and sources

• PDF from original source

Comments